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Randomised, controlled trial of alternating pressure mattresses
compared with alternating pressure overlays for the prevention of
pressure ulcers: PRESSURE (pressure relieving support surfaces)
trial
Jane Nixon, Gillian Cranny, Cynthia Iglesias, E Andrea Nelson, Kim Hawkins, Angela Phillips, David Torgerson, Su
Mason, Nicky Cullum, on behalf of the PRESSURE Trial Group
Abstract
Objective To compare whether differences exist between
alternating pressure overlays and alternating pressure
mattresses in the development of new pressure ulcers, healing
of existing pressure ulcers, and patient acceptability.
Design Pragmatic, open, multicentre, randomised controlled
trial.
Setting 11 hospitals in six NHS trusts.
Participants 1972 people admitted to hospital as acute or
elective patients.
Interventions Participants were randomised to an alternating
pressure mattress (n = 982) or an alternating pressure overlay
(n = 990).
Main outcome measures The proportion of participants
developing a new pressure ulcer of grade 2 or worse; time to
development of new pressure ulcers; proportions of
participants developing a new ulcer within 30 days; healing of
existing pressure ulcers; and patient acceptability.
Results Intention to treat analysis found no difference in the
proportions of participants developing a new pressure ulcer of
grade 2 or worse (10.7% overlay patients, 10.3% mattress
patients; difference 0.4%, 95% confidence interval − 2.3% to
3.1%, P = 0.75). More overlay patients requested change owing
to dissatisfaction (23.3%) than mattress patients (18.9%,
P = 0.02).
Conclusion No difference was found between alternating
pressure mattresses and alternating pressure overlays in the
proportion of people who develop a pressure ulcer.
Trial registration ISRCTN 78646179
Introduction
Pressure ulcers are areas of localised damage to the skin and
underlying tissue caused by pressure, shear, friction, or a combi-
nation of these.1 Pressure ulcers range in severity (box 1). They
are common in hospital, community, and nursing home popula-
tions (prevalence from 4% to 33%).2
Strategies to relieve pressure include manual repositioning
of patients or support surfaces such as cushions, mattress
overlays, replacement mattresses or pressure relieving beds. A
recent systematic review of 41 randomised controlled trials on
pressure relieving surfaces for prevention of pressure ulcers con-
cluded that the relative effectiveness of alternating pressure sur-
faces is unknown.4 Alternating pressure surfaces consist of air
filled sacs that sequentially inflate and deflate to relieve pressure
for short periods. They are provided as either a full size replace-
ment mattress or a shallower overlay that is placed on top of a
mattress and are commonly used for people at moderate to high
risk of pressure ulceration. An important clinical and economic
question is whether alternating pressure replacement mattresses
(about £4000; $7464; €5847) confer any advantages over
alternating pressure overlays (about £1000). We compared
whether differences exist between alternating pressure overlays
and alternating pressure mattresses in the development of new
pressure ulcers, healing of existing pressure ulcers, and patient
acceptability.
Methods
The pressure relieving support surfaces (PRESSURE) trial is a
multicentre, randomised, controlled, parallel group trial in 11
hospitals in six NHS trusts. The target population was
participants aged at least 55 years who had been admitted to vas-
cular, orthopaedic, medical, or care of elderly people wards,
either as acute or elective admissions, in the previous 24 hours.
Other eligibility criteria were expected length of stay of at least
seven days and either limitation of activity and mobility (Braden
scale activity and mobility scores of 1 or 2; box 25) or an existing
pressure ulcer of grade 2 (using the skin grading tool from
Nixon et al,3 box 1). Elective surgical patients without limitation
of activity and mobility or an existing pressure ulcer were eligible
if the average length of hospital stay for their surgical procedure
Box 1 Skin classification scale from Nixon et al3 with
permission of Blackwell
• Grade 0—no skin changes
• Grade 1a—redness to skin (blanching)
• Grade 1b—redness to skin (non-blanching)
• Grade 2—partial thickness wound involving epidermis or
dermis only
• Grade 3—full thickness wound involving subcutaneous tissue
• Grade 4—full thickness wound through subcutaneous tissue to
muscle or bone
• Grade 5—black eschar
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was at least seven days or they were expected to have Braden
scale activity and mobility scores of 1 or 25 for at least three days
postoperatively. Participants were not eligible if they had a pres-
sure ulcer on admission of grade 3 or worse, had a planned
admission to an intensive care unit after surgery, were admitted
to hospital more than four days before surgery, slept at night in a
chair, or weighed more than 140 kg or less than 45 kg (as per
mattress specifications).
Procedures
Randomisation was through an independent, secure, 24 hour
randomisation automated telephone system, ensuring allocation
concealment. We used minimisation so that groups were compa-
rable. We minimised on centre, existing pressure ulcer (yes or
no), specialty (vascular, orthopaedic, medical, or care of elderly
people), and type of admission (acute or elective).
Participants were allocated to an alternating pressure overlay
or an alternating pressure mattress (table 1) within 24 hours of
hospital admission. Elective surgical patients received their
device on the day before surgery or after surgery at the point of
transfer to bed.
The primary end point was the development of a new pres-
sure ulcer of grade 2 or worse (box 1) on any skin site after base-
line skin assessment and before trial completion. Clinical
research nurses assessed skin status twice weekly for 30 days and
then once a week up to 60 days. Grade 2 ulcers were chosen
because they represent a break in the skin that is clinically mean-
ingful and there is greater reliability in reporting these than for
grade 1 ulcers.3 Patient acceptability was assessed indirectly from
the number of people requesting a change because they were
dissatisfied with the assigned surface. Healing end points
included time to healing and grade of ulcer at trial completion.
Complete healing was defined as “complete re-epithelialisation”;
participants were considered “healed” if all their ulcers healed
during the trial period.
Trial completion was defined as participants fulfilling one of
the following criteria: improved mobility and activity (Braden
activity scores 3 or 4),5 a pressure ulcer of at least grade 2 that had
resolved for three consecutive days as well as improved mobility
and activity (Braden activity scores 3 or 4), transfer to a
non-participating ward or consultant, discharge from hospital,
60 days from randomisation, or death.
We obtained informed written consent from the patients or
assent from the relatives before participation. Relative assent was
obtained for participants who were unable to give informed con-
sent for reasons including unconsciousness, semiconsciousness,
and confusion. Individual consent was sought when participants
subsequently regained capacity.
Statistical analysis
We required a sample of 2000 participants for 80% power at the
5% significance level (two sided) to detect a 50% reduction in the
proportion of people developing a pressure ulcer of grade 2 or
worse. We aimed to recruit 2100 participants to allow for 5% loss
to follow-up. The analysis was by intention to treat, with partici-
pants being analysed according to the group to which they were
randomised.
The primary end point was compared between groups using
a 2 test. We also carried out logistic regression analysis to adjust
for minimisation factors and prespecified baseline covariates of
skin trauma on any site, wound on any site, non-blanching
erythema (grade 1b) on any site, patient’s age, Braden nutrition
score, haemoglobin level, Braden activity score, and diabetes. We
used a log rank test to compare the time to development of a
new pressure ulcer and a 2 test to compare the proportions of
participants who developed a new pressure ulcer within 30 days
of randomisation. As the data on area of new ulceration per
patient were skewed we compared the maximum total area
between the groups using a Mann-Whitney U test. We used a 2
test to compare the proportions of participants between groups
requesting a change owing to dissatisfaction with the trial
surface. A log rank test was used to compare time to complete
healing of existing ulcers between groups. We used a Cochran
Armitage test for trend to compare the maximum grade of exist-
ing ulcers at trial completion between groups, on a per patient
basis.
Results
Of 6155 people assessed for eligibility, 1972 were randomised
from 10 of the 11 hospitals between January 2001 and April
2004 (figure). One patient was randomised twice and therefore
excluded, providing an intention to treat population of 1971
people. The two groups were well balanced for baseline charac-
teristics (table 2).
Overall, 207 (10.5%) people developed a total of 305 new
pressure ulcers, most of which (n = 297) were grade 2 (97.4%).
Eight people developed grade 3 ulcers: three in the overlay
group and five in the mattress group. More of the acute patients
developed a new pressure ulcer than the elective patients; medi-
cal or elderly patients were more likely to develop a new pressure
ulcer than vascular or orthopaedic patients, and more people
with an existing grade 2 ulcer than without at randomisation
developed a new ulcer (table 3).
One hundred and six (10.7%) people in the overlay group
and 101 (10.3%) people in the mattress group developed one or
more new grade 2 pressure ulcers. The difference in the propor-
tions of people with a new pressure ulcer (overlay − mattress) was
0.4% (95% confidence interval − 2.3% to 3.1%). In the adjusted
analysis the odds ratio for developing a new pressure ulcer using
Box 2 Definitions of entry criteria for activity and
mobility
Bedfast
Confined to bed (activity score 1)
Chairfast
Ability to walk severely limited or non-existent
Cannot bear own weight or must be assisted into chair or wheel-
chair (activity score 2)
Completely immobile
Does not make even slight changes in body or extremity position
without assistance (mobility score 1)
Very limited mobility
Makes occasional slight changes in body or extremity position
but unable to make frequent or significant changes independ-
ently (mobility score 2)






Alternating cell height minimum
(cm)
8.5 19.6
Alternating cell height maximum
(cm)
12.25 29.4
Cell cycle time (minutes) 7.5-30 7.5-30
Cell cycle 1 in 2, 1 in 3, or 1 in 4 1 in 2, 1 in 3, or 1 in 4
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the overlay compared with the mattress was 0.94 (95%
confidence interval 0.68 to 1.29) indicating no difference
between the surfaces in the odds of developing a new pressure
ulcer (P = 0.70, logistic regression; table 4).
Factors that had a significant effect on the proportion of
people developing a new pressure ulcer were admission for an
acute condition, the presence of a wound, skin trauma or
non-blanching erythema on any site at baseline, age,
haemoglobin level, and diabetes (table 4).
No statistically significant differences between the groups
were found for development of a pressure ulcer within 30 days
(10.0% overlay v 9.3% mattress, P = 0.58, 2 test) or median time
to development of a new pressure ulcer for the mattress group
(56 days 95% confidence interval 48 days, upper limit not
estimable); the median for the overlay group had not been
reached (P = 0.76, log rank test). The groups had similar total
areas for ulcers, with most new ulcers being small (median area
1.1 cm2, range 0.1-68.1 cm2). No evidence was found of a differ-
ence in median ulcer area between the groups (1.2 cm2 overlay v
1.1 cm2 mattress, P = 0.98, Mann-Whitney U test).
Patient acceptability
In total 416 people requested one or more changes for comfort
and other device related reasons: 230 (23.3%) people in the
overlay group and 186 (18.9%) in the mattress group.
Significantly more people allocated overlays requested a change
(difference in proportions 4.4%, 95% confidence interval 0.7% to
7.9%; P = 0.02, 2 test).
Healing of existing pressure ulcers
Overall, 113 people had pressure ulcers at randomisation and, of
these, 39 (35%) healed during the trial: 34% (n = 20) in the over-
lay group and 35% (n = 19) in the mattress group. No statistically
significant differences were found between the groups for
median time to healing (20 days in both groups, P = 0.86, log
rank test) or the maximum final ulcer grade per patient (P = 0.96,
Cochran-Armitage test for trend).
In total, 349 (17.7%) participants were not placed on the
assigned surface at baseline: of these a device was unavailable for
43% (n = 151) and an alternative surface was allocated for 19%
(n = 66). More participants (n = 10) randomised to an overlay
than to a mattress (n = 2) were not placed on the assigned surface
because of a clinical decision. In addition, ward staff initiated the
change in surface for 149 (15.1%) people in the overlay group
and 142 (14.5%) people in the mattress group. Some evidence
was found of ward nurse preference for the replacement surface,
with people perceived to be at high risk but assigned to overlay
provided with a replacement mattress at baseline or subse-
Assessed for eligibility (n=6155)
Randomised (n=1972)
Not satisfying eligibility criteria (n=4183):
  No relatives present to consent (n=2286)
  Refused to consent (n=423)
  Non-designated consultant (n=316)
  Not admitted within time period (n=377)
  Weighed less than 45 kg (n=291) 
  Weighed more than 140 kg (n=68)
  Previous trial patient (n=153)
  Already on mattress (n=129)
  Refusal by relatives (n=72)
  Planned entry to intensive care unit (n=36)
  Slept in chair (n=30)
  On another research project (n=2)
Allocated to alternating pressure mattress
 (n=982)
Received mattress (n=804)
Did not receive mattress (n=178):
  Mattress unavailable (n=85)
  Clinical decision (n=2)
  Theatre organisation (n=11)
  Already on another mattress (n=35)
  Technical fault (n=2)
  Surgery cancelled (n=11)
  Withdrawn before receipt of mattress (n=3)
  Discharged before receipt of mattress (n=3)
  Reason not given (n=9)
  Other (n=17)
Allocated to alternating pressure overlay
 (n=990)
Received overlay  (n=818)
Did not receive overlay (n=171):
  Mattress unavailable (n=66)
  Clinical decision (n=10)
  Theatre organisation (n=19)
  Already on another mattress (n=31)
  Surgery cancelled (n=6)
  Withdrawn before receipt of overlay (n=3)
  Discharged before receipt of overlay (n=5)
  Reason not given (n=11)
  Other (n=20)
Lost to follow-up: no follow-up skin
assessments (n=51):
  Surgery cancelled (n=11)
  Transferred to a non-designated ward (n=7)
  Died (n=4)
  Discharged (n=14)
  Withdrawn (n=5)
  Missing forms (n=10)
Discontinued randomised intervention (n=287)
  Withdrawn after receipt of mattress (n=0)
  Changed from assigned mattress (n=287)*
*Of those who received the assigned mattress
at baseline
Lost to follow-up: no follow-up skin
assessments (n=66): 
  Surgery cancelled (n=6)
  Transferred to a non-designated ward (n=13)
  Died (n=10)
  Discharged (n=10)
  Withdrawn (n=15)
  Missing forms (n=12)
Discontinued randomised intervention (n=314)
  Withdrawn after receipt of overlay (n=1)
  Changed from assigned overlay (n=313)*
*Of those who received the assigned overlay
at baseline
Analysed (n=982)
  Excluded from analysis (n=0)
Analysed (n=989)
  Excluded from intention to treat analysis
  (n=1): patient had already participated in trial
Flow of participants through trial
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quently changed to a replacement mattress. Furthermore,
mattresses were more likely than overlays to be removed from a
trial patient and allocated to a patient considered needier. The
results of the cost effectiveness analysis are reported separately.6
Discussion
The proportion of patients allocated to an alternating pressure
overlay or alternating pressure mattress who developed a new
pressure ulcer of grade 2 or worse at any anatomical site did not
differ. These conclusions were confirmed by logistic regression
to adjust for prespecified covariates and minimisation factors.
Most people develop pressure ulcers early in their hospital
stay, but we found no statistically significant difference in the
median time to new ulceration or in the proportion of people
developing a new ulcer within 30 days. A cost effectiveness
analysis undertaken alongside this trial,6 however, concluded that
an alternating pressure mattress was cost effective as it was asso-
ciated with a delay in ulceration (measured by Kaplan Meier esti-
mates) and reduced costs as a consequence of shorter length of
hospital stay.
The patient acceptability results indicate greater dissatisfac-
tion with the overlay. Significantly more people using overlays
(23.3% v 18.9%) requested a change.
The analysis of risk factors confirmed the association of non-
blanching erythema7 8 and increasing age9 10 with pressure
ulceration whereas diabetes had only previously been identified
as a factor in elderly nursing home residents11 12 and anaemia in
intensive care patients.13 The part that diabetes may play in the
development of pressure ulcers is unclear; diabetic foot ulcers
are usually a version of pressure damage and whether people
with diabetes are more susceptible to pressure ulcers of the heel
is something that deserves further scrutiny.
Our trial has several strengths; it was adequately powered to
detect a clinically important effect on pressure ulcer risk even at
fairly low rates of ulcer incidence, it was pragmatic and the find-
ings are highly likely to be representative of what would happen
in usual clinical practice, and it had broad specifications for eligi-
ble mattresses and overlays that ensured the results are likely to
Table 2 Baseline characteristics of participants allocated to alternating
pressure overlay or alternating pressure mattress. Values are numbers






Mean (SD) age (years) 75.4 (9.7) 75.0 (9.2) 75.2 (9.5)
Median age (range) 76.0 (55.0-100.0) 75.0 (55.0-98.0) 76.0
(55.0-100.0)
Men 365 (36.9) 346 (35.2) 711 (36.1)
Women 624 (63.1) 636 (64.8) 1260 (63.9)
Smoker:
Yes 131 (13.2) 123 (12.5) 254 (12.9)
No 852 (86.1) 855 (87.1) 1707 (86.6)
Missing 6 (0.6) 4 (0.4) 10 (0.5)
Diabetes:
Yes 88 (8.9) 102 (10.4) 190 (9.6)
No 895 (90.5) 875 (89.1) 1770 (89.8)
Missing 6 (0.6) 5 (0.5) 11 (0.6)
History of weight loss*:
Yes 75 (7.6) 95 (9.7) 170 (8.6)
No 904 (91.4) 881 (89.7) 1785 (90.6)
Missing 10 (1.0) 6 (0.6) 16 (0.8)
Haemoglobin level (g/l)†:
Mean (SD) 129 (18) 130 (17) 129 (18)
Median (range) 131 (38-190) 131 (49-184) 131 (38-190)
Missing 53 50 103
Skin trauma:
Yes 64 (6.5) 64 (6.5) 128 (6.5)
No 925 (93.5) 918 (93.5) 1843 (93.5)
Wound‡:
Yes 57 (5.8) 60 (6.1) 117 (5.9)
No 932 (94.2) 922 (93.9) 1854 (94.1)
Non-blanching erythema
(grade 1b):
Yes 180 (18.2) 145 (14.8) 325 (16.5)
No 809 (81.8) 837 (85.2) 1646 (83.5)
Braden scale activity:
Bedfast 804 (81.3) 754 (76.8) 1558 (79.0)
Chairfast 87 (8.8) 124 (12.6) 211 (10.7)
Walks occasionally 20 (2.0) 31 (3.2) 51 (2.6)
Walks frequently 52 (5.3) 49 (5.0) 101 (5.1)
Missing 26 (2.6) 24 (2.4) 50 (2.5)
Braden scale nutrition:
Very poor 403 (40.7) 371 (37.8) 774 (39.3)
Probably inadequate 304 (30.7) 323 (32.9) 627 (31.8)
Adequate 185 (18.7) 196 (20.0) 381 (19.3)
Excellent 71 (7.2) 67 (6.8) 138 (7.0)
Missing 26 (2.6) 25 (2.5) 51 (2.6)
*Weight loss >6 kg in past six months.
†Measured on admission or preoperatively.
‡Wound on any site at baseline—for example, leg ulcer, diabetic ulcer, surgical wound, and
ischaemic or vascular ulcer.









Acute 88/488 (18.0) 84/483 (17.4) 172/971 (17.7)
Elective 18/501 (3.6) 17/499 (3.4) 35/1000 (3.5)
Type of specialty:
Vascular 3/36 (8.3) 6/38 (15.8) 9/74 (12.2)
Orthopaedic 75/785 (9.6) 66/779 (8.5) 141/1564 (9.0)
Elderly or medical 28/168 (16.7) 29/165 (17.6) 57/333 (17.1)
Existing grade 2 pressure ulcer:
Yes 10/59 (16.9) 10/54 (18.5) 20/113 (17.7)
No 96/930 (10.3) 91/928 (9.8) 187/1858 (10.1)
Table 4 Adjusted analysis of proportion of patients developing a new
pressure ulcer of grade 2 or worse
Variable Odds ratio (95% CI) P value
Support surface (overlay: mattress) 0.94 (0.68 to 1.29) 0.70
Hospital* 0.02
Admission* (acute: elective) 3.65 (2.27 to 5.85) <0.0001
Specialty*:
Vascular v care of elderly people 1.31 (0.51 to 3.33) 0.54
Orthopaedic v care of elderly people 1.28 (0.82 to 2.01)
Existing pressure ulcer* (yes v no) 0.97 (0.52 to 1.79) 0.92
Baseline wound (yes v no) 2.96 (1.73 to 5.08) <0.0001
Baseline skin trauma (yes v no) 1.67 (0.999 to 2.80) 0.05
Baseline ulcer grade 1b (yes v no) 1.95 (1.31 to 2.91) 0.001
Age (years) 1.02 (1.002 to 1.04) 0.03
Diabetes (yes v no) 1.61 (1.007 to 2.56) 0.047
Braden activity:
Bedfast v walks frequently 0.70 (0.19 to 2.59) 0.22
Chairfast v walks frequently 0.36 (0.09 to 1.52)
Walks occasionally v walks frequently 0.91 (0.16 to 5.08)
Braden nutrition (very poor or inadequate v
adequate or excellent)
1.31 (0.81 to 2.13) 0.28
Haemoglobin level on admission or
preoperatively (g/l)
8.9 (8.2 to 9.7) 0.1
Small hospitals (<50 inpatient beds) were combined for analysis purposes to prevent
problems from model convergence.
*Minimisation factors.
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be applicable to any surfaces that match these specifications.
Finally, the rate of pressure ulceration (10%) was well within the
range of risk reported in previous trials in similar populations
incorporating an alternating pressure arm.4
The main limitation of our trial was the lack of blinded out-
come assessment; this is probably impossible to achieve in such
trials because it is difficult to disguise or mask the mattresses and
it would be unethical to frequently move seriously ill, elderly
people on to a standard surface for their skin to be assessed. We
took steps to minimise the potential for bias this allows by
collecting independent skin assessments carried out by both the
ward staff and the clinical research nurses.3 Although ward
nurses were not blind to allocation, we have no evidence that this
influenced the care given. The frequent mattress changes were a
strength of this trial as they represent the use of mattresses in
real life and provide generalisable data.
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What is already known on this topic
No trials have directly compared alternating pressure
replacement mattresses with less costly overlays in the
prevention of pressure ulcers
What this study adds
No difference was found between alternating pressure
replacement mattresses and alternating pressure overlays in
proportion of people who develop pressure ulcers
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